Literature DB >> 16985802

Practical management of recurrent urinary tract infections in premenopausal women.

J Curtis Nickel.   

Abstract

Recurrent urinary tract infections (UTIs) are a major healthcare concern for premenopausal, healthy, sexually active women. A practical approach to the management and prevention of recurrent UTIs should be simple, practical, and cost effective. Low-dose or postcoital antimicrobial therapy can be effective for women with constellations of many recurrent UTIs, but for women with 2 to 4 UTIs per year, the most cost-effective and empowering management strategy is patient-initiated antimicrobial treatment.

Entities:  

Year:  2005        PMID: 16985802      PMCID: PMC1477561     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  20 in total

1.  Efficacy and safety of self-start therapy in women with recurrent urinary tract infections.

Authors:  A J Schaeffer; B A Stuppy
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

2.  Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women.

Authors:  K Gupta; T M Hooton; P L Roberts; W E Stamm
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

3.  Cranberry concentrate: UTI prophylaxis.

Authors:  E B Walker; D P Barney; J N Mickelsen; R J Walton; R A Mickelsen
Journal:  J Fam Pract       Date:  1997-08       Impact factor: 0.493

Review 4.  Recurrent urinary tract infection in adult women: diagnosis and treatment.

Authors:  L E Nicolle; A R Ronald
Journal:  Infect Dis Clin North Am       Date:  1987-12       Impact factor: 5.982

Review 5.  Diagnosis and treatment of uncomplicated urinary tract infection.

Authors:  T M Hooton; W E Stamm
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

6.  Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.

Authors:  D T Uehling; W J Hopkins; E Balish; Y Xing; D M Heisey
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

7.  Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation.

Authors:  K Gupta; S L Hillier; T M Hooton; P L Roberts; W E Stamm
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

8.  A prospective study of risk factors for symptomatic urinary tract infection in young women.

Authors:  T M Hooton; D Scholes; J P Hughes; C Winter; P L Roberts; A E Stapleton; A Stergachis; W E Stamm
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

9.  Recurrent urinary tract infections in premenopausal women: prophylaxis based on an understanding of the pathogenesis.

Authors:  A Pfau; T Sacks; D Engelstein
Journal:  J Urol       Date:  1983-06       Impact factor: 7.450

10.  Value of urologic investigation in a targeted group of women with recurrent urinary tract infections.

Authors:  J C Nickel; J Wilson; A Morales; J Heaton
Journal:  Can J Surg       Date:  1991-12       Impact factor: 2.089

View more
  14 in total

1.  Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.

Authors:  Lee W Goneau; Nigel S Yeoh; Kyle W MacDonald; Peter A Cadieux; Jeremy P Burton; Hassan Razvi; Gregor Reid
Journal:  Antimicrob Agents Chemother       Date:  2014-01-21       Impact factor: 5.191

2.  Efficacy of vaccination with StroVac for recurrent urinary tract infections in women: a comparative single-centre study.

Authors:  Sebastian Nestler; Britta Grüne; Lydia Schilchegger; Adriana Suna; Anita Perez; Andreas Neisius
Journal:  Int Urol Nephrol       Date:  2021-09-09       Impact factor: 2.266

3.  Microbiology testing and antibiotic treatment for urinary tract infections in general practice: a nationwide observational study.

Authors:  Zhuoxin Peng; Andrew Hayen; John Hall; Bette Liu
Journal:  Infection       Date:  2020-08-29       Impact factor: 3.553

4.  An economic perspective on urinary tract infection: the "costs of resignation".

Authors:  Oriana Ciani; Daniele Grassi; Rosanna Tarricone
Journal:  Clin Drug Investig       Date:  2013-04       Impact factor: 2.859

5.  D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial.

Authors:  Bojana Kranjčec; Dino Papeš; Silvio Altarac
Journal:  World J Urol       Date:  2013-04-30       Impact factor: 4.226

Review 6.  Urinary tract infections: current and emerging management strategies.

Authors:  Amelia E Barber; J Paul Norton; Adam M Spivak; Matthew A Mulvey
Journal:  Clin Infect Dis       Date:  2013-05-03       Impact factor: 9.079

Review 7.  A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections.

Authors:  Michael McDonald; Darian Kameh; Mark E Johnson; Truls E Bjerklund Johansen; David Albala; Vladimir Mouraviev
Journal:  Rev Urol       Date:  2017

8.  Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection.

Authors:  Ivy Y Ge; Helene B Fevrier; Carol Conell; Malika N Kheraj; Alexander C Flint; Darvin S Smith; Lisa J Herrinton
Journal:  Ther Adv Urol       Date:  2018-06-22

9.  Cysticlean® a highly pac standardized content in the prevention of recurrent urinary tract infections: an observational, prospective cohort study.

Authors:  Francisco Sánchez Ballester; Vicente Ruiz Vidal; Emilio López Alcina; Cristina Domenech Perez; Eva Escudero Fontano; Ana Oltra Benavent; Ana Montoliu García; Marco Sobrón Bustamante
Journal:  BMC Urol       Date:  2013-06-05       Impact factor: 2.264

Review 10.  Cystitis: from urothelial cell biology to clinical applications.

Authors:  Gilho Lee; Rok Romih; Daša Zupančič
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.